Make your mark for patients.

We're here because we want to build the future and transform patients' lives for the better.

At UCB, our people are our experiences and achievements, our passion and drive. That's why we're looking for talented individuals with diverse backgrounds and experiences - not just the best and brightest, but those who care about making a meaningful difference in the lives of patients. We promote an environment of diversity, openness, and respect where people can make valuable contributions.

An exciting journey lies ahead. Will you join us in pushing the boundaries of what's possible?

To strengthen our Global Rare medical team in the Rare Disease Organization (RDO), we are looking for a talented individual with experience in Rare/Ultra-rare Genetic or Metabolic Diseases to fill the position of: Global Medical Lead - Thymidine Kinase 2 deficiency (TK2d)/Mitochondrial Disease to be based in our HQ in Brussels, Belgium, and US - (east coast preferred) or other locations in Europe.

The global medical lead (GML) Thymidine Kinase 2 deficiency (TK2d)/Mitochondrial Disease is a member of the Rare Medical team, reports to the Global Medical Indication Lead (GMIL) and provides therapeutic area expertise - defined as a deep understanding of the relevant disease and its physician and patient journey. The Global Medical lead has the scientific, clinical, or academic credentials and experience to be able to engage with thought leaders and other stakeholders in the therapeutic area (TA).

You like to work in anenvironment whereyou can:

• Work collaboratively in a cross-functional team to impact and build a better world for people with rare diseases.
• Be a key point person and trusted partner in the specific disease area working with the Development and Commercial/Market Access, to provide medical leadership and disease area expertise.
• Show your familiarity or develop familiarity with the disease area and the evolving patient and physician journey when new treatment options emerge
• Identify Centers of Excellence and develop global expert networks, build partnerships, and collaborate with patient organizations and private companies in the Rare Disease space
• Articulate the value of treatment, based on the integration of various sources of data, including UCB sponsored interventional and non-interventional clinical studies, external databases, and literature. The GML has a key role in contributing to the integration and interpretation of these various data sources and translates these into medical strategy and tactics, including communication, education to a variety of stakeholders (global, regional, local), tailoring these as needed. The medical lead ensures scientific integrity and balanced reflection of the interpretation and dissemination of the data.

You will contributeby:

• Working with the Global Medical Indication Lead (GMIL) and the cross-functional team to develop and execute the global medical strategy and related tactics, appropriately aligned with overall UCB/RDO strategy as a standing member of the Global Medical Indication Team (GMIT).
• Providing medical leadership as Global Medical representative on project-based teams for the indication.
• Acting as a company representative with external scientific leaders/physicians, patient organizations and regulatory authorities
• Establishing strategic world-wide partnerships with small numbers of centers of excellence (CoE) and thought leaders in the Rare Disease space. Building strong relationships, based on patient focus, integrity, and trust with the network and ecosystem of the specific indication to demonstrate UCB's long term commitment to the disease area, and to leverage this network to provide world class expertise to guide the evidence generation plan for maximal patient benefit.
• Identifying data and insight gaps and define strategies and tactics to address these gaps proactively using a diverse selection of appropriate methods to generate insights and data (e.g., advisory boards, scientific data generation efforts, other).
• Provide Medical Leadership for proactive and reactive scientific communication to raise disease awareness and to communicate about the treatment value as this evidence grows, using publications, scientific presentations, and other external communication platforms, ensuring transparency and consistency.
• Ensuring that the treatment value is articulated in a scientific way in the framework of Health Technology Assessment (HTA) discussion.
• Ensuring in close collaboration with Patient Engagement and the Safety Lead that communication with patients about benefit/risk is using the right lay language, resulting in a balanced presentation of the benefit/risk

Detailed responsibilities description

• Support development and execution of the global medical strategy, global/regional/local tactical plans, and evidence generation plan. This will require close collaboration with the GMIL, the Scientific Communication, Publication, Patient Engagement and Evidence Generation Leads, other cross-functional partners and regional/local representatives.
• Support medical review and approval of medical, promotional, and meeting materials
• Review and contribute to regulatory obligations in close collaboration with the filing team
• As delegated by the GMIL, lead functional and project teams (e.g., publications, medical communications, medical training) in developing plans supporting global medical strategy and collaborate with commercial/market access to ensure aligned and medically appropriate commercial strategy, planning, and execution of the Patient Value Brand Plan
• As delegated by the GMIL, directly implement global medical strategy, including:
  • Support efforts to enhance genetic testing and/or newborn screening in different geographies to enable earlier patient diagnosis for the specific indication
  • Support the efforts to enhance collaborations with CoE, academic institutions, patient organizations and private companies to raise awareness and enhance diagnosis through innovative educational projects and research collaborations
  • Support the development of a UCB's Managed Access Program (MAP) for the specific indication
  • Providing guidance for scientific communications, including standard responses and publications
  • Planning and managing global and overseeing regional medical Advisory Boards
  • Providing medical review of Investigator Initiated Studies (IIS) proposals, collaborative studies aligned with the global IIS strategy and other Medical led studies, educational grants through the grant approval process
  • Managing design and execution of clinical studies (phase IIIb/IV, disease registries, epidemiological studies, outcomes surveys, etc.) in close collaboration with Evidence Generation Leads, RWE, Therapeutic Development leads and Clinical Operations

Interested? For this position you'll need the followingeducation, experienceand skills:

• A medical degree (M.D.) is preferred, with a specialist certification in a specific disease area
• More than 5 years' experience in international or global role in medical affairs in the pharmaceutical industry with strong knowledge of the overall drug development process as well as of health economy and access considerations and principles.
• Experience in (Ultra-)Rare disease space, especially genetic or metabolic disease, is preferred.
• Experience in the disease area of interest through clinical or biopharmaceutical experience is preferred
• Experience in genetic testing or genetic screening programs is, as disease awareness campaigns and compassionate use programs is an advantage
• Maintains extensive knowledge of the relevant therapeutic areas, diseases, stakeholders, patient journeys and unmet needs, clinical practice, research, and development, regulatory, market access environment, and the competitive landscape.
• Creates and implements patient-focused and patient-driven solutions that engage patients and internal/external stakeholders to understand the patient's disease journey
• Anticipates trends and interprets signals in the ecosystem of care and maintains a holistic perspective of medical affairs-related activities externally and within UCB; combines this view with a patient-value focus and business understanding to develop high-impact solutions.
• Works collaboratively to ensure the highest healthcare principles and standards are upheld, while creating agile frameworks and programs in a cross-functional setting to deliver results that maximize patient value.
• Summarizes relevant benefit/risk information, clearly articulates, and presents medical and scientific concepts pertaining to value and benefit-risk assessments in scientific and clinical settings, and appropriately shares the information to enable informed decision making.
• Identifies and defines research questions and strategy, relevant data sources, methodologies and systems for safety and effectiveness analysis in a rapidly evolving ecosystem; Executes/interpret analysis to answer the research questions to enable informed decision making.
• Understands the value of technology for high quality, consistent and efficient data capture, processing, and analysis, including AI.
• Ability to collaboratively build, control, and continuously adapt the project plan, with the appropriate level of details, to achieve the project objectives.
• Gathering and interpretation of information: Uses quantitative and qualitative methods to obtain relevant information about stakeholders' needs, motivations, and behaviors in order to contribute to the generation of insights.
• Manages the process and/or teams to produce a deep understanding of stakeholders' and/or patients' needs.
• Leading others: Communicates the vision and sense of purpose with enthusiasm, and ensures strategic priorities are understood and acted upon
• Shows trust and provides learning opportunities to reports through delegation and opportunity for participation in new and stretching assignments

Why you should apply

At UCB, we strive to attract passionate and outstanding talents who thrive on change and are ready to bring real value to patients. Working for us you'll discover a place where you can grow and express your full potential. We place an emphasis on innovation, collaboration and impact.

Through meaningful recognition and a challenging international work atmosphere, we aim to provide an optimal experience by caring about and valuing our employees - just as we do for the patients we serve. Join us!

About UCB in Rare Diseases

We're driven by patient value, not patient numbers.

People with rare diseases often feel forgotten, unheard or misunderstood. The challenges they face can be magnified by isolation, and they may wonder if anyone else cares about what they need. They worry their disease affects too few people for anybody to care.

The greatest needs can't always be measured in numbers. At UCB, we don't just see patients or population sizes, we see people in need. Through decades of serving the neurology and immunology communities, we have improved lives with impactful medicines and by enhancing the social and emotional well-being of patients. As a continuation of our heritage, and a progression of our science, we are expanding our efforts to developing treatments for rare neurological and immunologic diseases where current options offer little hope. We believe our scientific strength in these fields can create genuine value for the patient communities we serve.

Curious to know more? Please visit our website .

UCB and its subsidiaries encourage diversity and inclusion in the workplace; we are an Equal Opportunity Employer.

About us.

UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are around 7,600 people in all four corners of the globe, inspired by patients and driven by science.

At UCB, everything we do start with a simple question: "How will this create value for people living with severe disease?". We are on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. We want to ensure the creation of patient value, now and into the future, while contributing to a society where a population of 8 billion people and more should be able to live a good life within limited resources of one planet.

Curious to know more? Please visit our website .

UCB and its subsidiaries encourage diversity and inclusion in the workplace; we are an Equal Opportunity Employer. We do not discriminate on the basis of race/color/religion/sex/national origin/veteran/disability/age/sexual orientation/gender identity.